455 related articles for article (PubMed ID: 16111569)
21. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennett C; Engert A
J Natl Cancer Inst; 2005 Apr; 97(7):489-98. PubMed ID: 15812074
[TBL] [Abstract][Full Text] [Related]
22. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
Nowrousian MR; Dunst J; Vaupel P
Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
[TBL] [Abstract][Full Text] [Related]
23. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
Thomas ML
Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
[TBL] [Abstract][Full Text] [Related]
24. Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life.
Cortesi E; Gascón P; Henry D; Littlewood T; Milroy R; Pronzato P; Reinhardt U; Shasha D; Thatcher N; Wilkinson P
Oncology; 2005; 68 Suppl 1():22-32. PubMed ID: 15855813
[TBL] [Abstract][Full Text] [Related]
25. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
Hoskin PJ; Saunders MI; Dische S
Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and outcomes of anemia in cancer: a systematic review of the literature.
Knight K; Wade S; Balducci L
Am J Med; 2004 Apr; 116 Suppl 7A():11S-26S. PubMed ID: 15050883
[TBL] [Abstract][Full Text] [Related]
27. Correction of cancer anemia--impact on disease course, prognosis and treatment efficacy, particularly for patients undergoing radiotherapy.
Henke M
Onkologie; 2001 Oct; 24(5):450-4. PubMed ID: 11694771
[TBL] [Abstract][Full Text] [Related]
28. [Erythropoietin and radiation therapy].
Hennequin C
Bull Cancer; 2006 May; 93(5):495-9. PubMed ID: 16777628
[TBL] [Abstract][Full Text] [Related]
29. Anemia, hypoxia and transfusion in patients with cervix cancer: a review.
Fyles AW; Milosevic M; Pintilie M; Syed A; Hill RP
Radiother Oncol; 2000 Oct; 57(1):13-9. PubMed ID: 11033184
[TBL] [Abstract][Full Text] [Related]
30. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
Durmaz O; Demirkaya M; Sevinir B
Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
[TBL] [Abstract][Full Text] [Related]
32. Anemia in lung cancer: clinical impact and management.
Pirker R; Wiesenberger K; Pohl G; Minar W
Clin Lung Cancer; 2003 Sep; 5(2):90-7. PubMed ID: 14596691
[TBL] [Abstract][Full Text] [Related]
33. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
34. Impact of tumor hypoxia and anemia on radiation therapy outcomes.
Harrison LB; Chadha M; Hill RJ; Hu K; Shasha D
Oncologist; 2002; 7(6):492-508. PubMed ID: 12490737
[TBL] [Abstract][Full Text] [Related]
35. Clinical studies of hypoxia modification in radiotherapy.
Kaanders JH; Bussink J; van der Kogel AJ
Semin Radiat Oncol; 2004 Jul; 14(3):233-40. PubMed ID: 15254866
[TBL] [Abstract][Full Text] [Related]
36. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
Saunders M; Dische S
Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
[TBL] [Abstract][Full Text] [Related]
37. [Anemia in head and neck cancers].
Azria D; Zouhair A; Serre A; Lemanski C; Schneider M; Ozsahin M; Dubois JB; Lartigau E;
Bull Cancer; 2005 May; 92(5):445-51. PubMed ID: 15932808
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
39. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy.
Hoff CM
Acta Oncol; 2012 Apr; 51(4):419-32. PubMed ID: 22313317
[TBL] [Abstract][Full Text] [Related]
40. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
